Dr. Leung Ian Yu Hin - Neurology
Specialist in Neurology
Highlights
- MCHK RegisteredVerified
- Specialist in NeurologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Physicians · Medical degree 2015
- InsuranceBeing compiled｜See details
About
Dr. Leung Ian Yu Hin is a registered Neurology specialist in Hong Kong.
Education
Specialist in Neurology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2015
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Leung Ian Yu Hin? Claim page and update insurance →
FAQ
Is Dr. Leung Ian Yu Hin any good?
Dr. Leung Ian Yu Hin is a registered Neurology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Leung Ian Yu Hin do?
Dr. Leung Ian Yu Hin practises in Neurology.
Are you Dr. Leung Ian Yu Hin? Claim this page to update and manage.
ClaimResearch and publications
6 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Sex-specific elevated incidence of glaucoma associated with topiramate versus valproate or lamotrigine in epilepsy, not migraine: A population-based cohort study.Epilepsia · 2026
- Efficacy and Tolerability of Brivaracetam in Chinese Population: Focus on Switch From Levetiracetam.American journal of therapeutics · 2023
- Low-Density Lipoprotein Cholesterol and Risk of Recurrent Vascular Events in Chinese Patients With Ischemic Stroke With and Without Significant Atherosclerosis.Journal of the American Heart Association · 2021
- Seasonality in the incidence of anti-GQ1b antibody syndrome-A territory-wide study.Brain and behavior · 2021
- Efficacy upon 12-weeks after achievement of maximal dose and tolerability of lacosamide as an adjunctive therapy in epilepsy: Real world clinical experience.Journal of the neurological sciences · 2020
- Efficacy and tolerability of perampanel as an adjunct therapy in refractory epilepsy from real-world experience.Journal of the neurological sciences · 2019
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer